Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 7—July 2011

Dispatch

Visceral Larva Migrans in Immigrants from Latin America

Maria-Carmen Turrientes, Ana Pérez de Ayala, Francesca Norman, Miriam Navarro, José-Antonio Pérez-Molina, Mercedes Rodriquez-Ferrer, Teresa Gárate, and Rogelio López-VélezComments to Author 
Author affiliations: Author affiliations: Ramón y Cajal Hospital, Madrid, Spain (M.-C. Turrientes, A. Pérez de Ayala, F. Norman, M. Navarro, J.-A. Pérez-Molina, R. López-Vélez); Institute de Salud Carlos III, Madrid (T. Gárate, M. Rodriquez-Ferrer)

Main Article

Table

Descriptions of 4 cases of visceral larva migrans in immigrants from Latin America, Spain, April 1989–June 2008*

Case no.
Age, y/sex
Origin
Clinical signs and symptoms
Chest radiograph results
Eosinophil count,
absolute/mm3 (%)
6-mo follow-up
Eosinophil count/mm3
Decrease in antibody titers
Symptoms
1 28/M Bolivia Asthma-like syndrome† Slight right parahiliar infiltrate 700 (17.0) 500 Yes None
2 29/F Dominican Republic Dry cough, dyspnea, chest pain, eosinophilic pneumonia Bilateral alveolar infiltrates 1,400 (10.5) 600 Yes None
3 5/F Ecuador Asthma-like syndrome, abdominal pain No findings 1,050 (15.0) 700 Yes None
4 40/F Colombia Abdominal pain Not done 1,500 (14.8) 400 Yes Clinical improvement

*All patients were treated with albendazole (10–15 mg/kg/d in 2 doses orally for 5 days).
†Wheezing and dry cough.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO